VSCP / VirtualScopics, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

VirtualScopics 15-12G

15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-52018 VIRTUALSCOPICS, INC. (Exact name of registrant as specified

BYLAWS VIRTUALSCOPICS, INC. ARTICLE I Meetings of Stockholders

EX-3.2 Exhibit 3.2 BYLAWS OF VIRTUALSCOPICS, INC. ARTICLE I Meetings of Stockholders Section 1.1 Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution of the Board of Directors from time to time. Any other p

May 11, 2016

EX-10.1 Exhibit 10.1 May 11, 2016 Mr. Eric T. Converse 6893 Sladek Road New Hope, PA 18938 RE: Separation and Release Agreement Dear Eric: As you are aware, VirtualScopics, Inc. (the “Company”) has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with BioTelemetry, Inc., a Delaware corporation (the “Purchaser”) and BioTelemetry Research Acquisition Corporation, a Delaware corp

CERTIFICATE OF INCORPORATION VIRTUALSCOPICS, INC. ARTICLE I

EX-3.1 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF VIRTUALSCOPICS, INC. ARTICLE I The name of the corporation is VIRTUALSCOPICS, INC. (the “Corporation”). ARTICLE II The address of the registered office of the Company in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, State of Delaware 19801 and the name of the registered agent of th

VirtualScopics 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 11, 2016 VirtualScopics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 000-52018 04-3007151 (State or Other Jurisdiction of Incorporation) (Commission F

VirtualScopics FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52018 VirtualScopics, Inc. (E

AMENDED AND RESTATED BY-LAWS VIRTUALSCOPICS, INC. Amended and Restated as of March 25, 2016 ARTICLE I

EX-3.1 2 v438816ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 AMENDED AND RESTATED BY-LAWS Of VIRTUALSCOPICS, INC. Amended and Restated as of March 25, 2016 ARTICLE I OFFICES 1.1 REGISTERED OFFICE. The registered office shall be established and maintained at Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware in the County of New Castle in the State of Delaware. 1.2 OTHER OFFICES. The corporati

VirtualScopics S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on May 11, 2016 Registration No.

VirtualScopics S-8 POS

S-8 POS 1 d194258ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on May 11, 2016 Registration No. 333-162253 Registration No. 333-147718 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO Form S-8 Registration Statement No. 333-162253 Form S-8 Registration Statement No. 333-147718 UNDER THE SECURITIES ACT OF 1933 Virtua

VSCP / VirtualScopics, Inc. / Merck & Co., Inc. - AMENDMENT NO. 2 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* VIRTUALSCOPICS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 928269-10-9 (CUSIP Number) William Taranto, Manager / President Merck Global Health Innovation Fund, LLC Two Merck Drive Mailstop 2W17 Whitehouse Station, NJ 08889 908-423-

VirtualScopics SC 14D9/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14D-9 (Amendment No. 1) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) VIRTUALSCOPICS, INC. (Names of Persons Filing Statement) Common Stock, par value $0.001 per share Series A Convertible Preferred Stock, par value $0

VirtualScopics SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No.1) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) BIOTELEMETRY RESEARCH ACQUISITION CORPORATION (Offeror) BIOTELEMETRY, INC. (Parent of Offeror) (Names of Filing Persons) COMMON STOCK, $0.001 PAR

BIOTELEMETRY, INC. ANNOUNCES RESULTS OF TENDER OFFER FOR SHARES OF VIRTUALSCOPICS, INC.

EX-99.(a)(1)(i) Exhibit (a)(1)(I) BIOTELEMETRY, INC. ANNOUNCES RESULTS OF TENDER OFFER FOR SHARES OF VIRTUALSCOPICS, INC. MALVERN, Pa., May 10, 2016 (GLOBE NEWSWIRE) ? BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly

VirtualScopics 10-K/A (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52018 VIRTU

VirtualScopics, Inc. 500 Linden Oaks Rochester, New York 14625 (585) 249-6231

Exhibit (e)(4) VirtualScopics, Inc. 500 Linden Oaks Rochester, New York 14625 (585) 249-6231 STRICTLY CONFIDENTIAL June 24, 2015 Peter Ferola BioTelemetry, Inc. 1000 Cedar Hollow Road Malvern, Pennsylvania 19355 Dear Mr. Ferola: Re: Proposed Discussions In connection with your consideration of a possible negotiated transaction (?Transaction?) involving VirtualScopics, Inc., a Delaware corporation

VirtualScopics SC 14D9

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) VIRTUALSCOPICS, INC. (Names of Persons Filing Statement) Common Stock, par value $0.001 per share Series A Convertible Preferred Stock, par value $0.001 per share Ser

Offer to Purchase for Cash All Outstanding Shares of Common Stock All Outstanding Shares of Series A Convertible Preferred Stock All Outstanding Shares of Series B Convertible Preferred Stock All Outstanding Shares of Series C-1 Convertible Preferred

EX-99.A1.A Table of Contents Exhibit (a)(1)(A) Offer to Purchase for Cash All Outstanding Shares of Common Stock All Outstanding Shares of Series A Convertible Preferred Stock All Outstanding Shares of Series B Convertible Preferred Stock All Outstanding Shares of Series C-1 Convertible Preferred Stock of VirtualScopics, Inc. at $4.05 Net Per Share of Common Stock; $336.30 Net Per Share of Series

Offer To Purchase For Cash All Outstanding Shares of Common Stock All Outstanding Shares of Series A Convertible Preferred Stock All Outstanding Shares of Series B Convertible Preferred Stock All Outstanding Shares of Series C-1 Convertible Preferred

EX-99.A1.D 5 d177976dex99a1d.htm EX-99.A1.D Exhibit (a)(1)(D) Offer To Purchase For Cash All Outstanding Shares of Common Stock All Outstanding Shares of Series A Convertible Preferred Stock All Outstanding Shares of Series B Convertible Preferred Stock All Outstanding Shares of Series C-1 Convertible Preferred Stock of VirtualScopics Inc. at $4.05 Net Per Share of Common Stock; $336.30 Net Per Sh

Offer To Purchase For Cash All Outstanding Shares of Common Stock All Outstanding Shares of Series A Convertible Preferred Stock All Outstanding Shares of Series B Convertible Preferred Stock All Outstanding Shares of Series C-1 Convertible Preferred

EX-99.A1.E 6 d177976dex99a1e.htm EX-99.A1.E Exhibit (a)(1)(E) Offer To Purchase For Cash All Outstanding Shares of Common Stock All Outstanding Shares of Series A Convertible Preferred Stock All Outstanding Shares of Series B Convertible Preferred Stock All Outstanding Shares of Series C-1 Convertible Preferred Stock of VirtualScopics Inc. at $4.05 Net Per Share of Common Stock; $336.30 Net Per Sh

TENDER AND SUPPORT AGREEMENT

EX-99.D2 Exhibit (d)(2) TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT, dated as of March 25, 2016 (this ?Agreement?), among Biotelemetry, Inc., a Delaware corporation (?Parent?), Biotelemetry Research Acquisition Corporation, a Delaware corporation (?Merger Sub?), and Loeb Investors Company 147, LP, a Delaware limited partnership (the ?Stockholder?). WHEREAS, as a condition and inducem

For Tender of Shares of Common Stock Series A Convertible Preferred Stock Series B Convertible Preferred Stock Series C-1 Convertible Preferred Stock VirtualScopics Inc. a Delaware corporation $4.05 Net Per Share of Common Stock; $336.30 Net Per Shar

EX-99.A1.C Exhibit (a)(1)(C) For Tender of Shares of Common Stock Series A Convertible Preferred Stock Series B Convertible Preferred Stock Series C-1 Convertible Preferred Stock of VirtualScopics Inc. a Delaware corporation at $4.05 Net Per Share of Common Stock; $336.30 Net Per Share of Series A Convertible Preferred Stock; $336.30 Net Per Share of Series B Convertible Preferred Stock; and $920.

LETTER OF TRANSMITTAL To Tender Shares of Common Stock Series A Convertible Preferred Stock Series B Convertible Preferred Stock Series C-1 Convertible Preferred Stock VirtualScopics Inc. a Delaware corporation $4.05 Net Per Share of Common Stock; $3

EX-99.A1.B Exhibit (a)(1)(B) LETTER OF TRANSMITTAL To Tender Shares of Common Stock Series A Convertible Preferred Stock Series B Convertible Preferred Stock Series C-1 Convertible Preferred Stock of VirtualScopics Inc. a Delaware corporation at $4.05 Net Per Share of Common Stock; $336.30 Net Per Share of Series A Convertible Preferred Stock; $336.30 Net Per Share of Series B Convertible Preferre

This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below), and the provisions herein are subject in their entirety to the provisions of the Offer (as defined below). The Offer is made solely by

EX-99.A1.F Exhibit (a)(1)(F) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below), and the provisions herein are subject in their entirety to the provisions of the Offer (as defined below). The Offer is made solely by the Offer to Purchase, dated April 8, 2016, and the related Letter of Transmittal and any amendments or supplements ther

TENDER AND SUPPORT AGREEMENT

Exhibit (d)(3) TENDER AND SUPPORT AGREEMENT TENDER AND SUPPORT AGREEMENT, dated as of March 25, 2016 (this “Agreement”), among Biotelemetry, Inc.

BIOTELEMETRY, INC. COMMENCES PREVIOUSLY ANNOUNCED TENDER OFFER TO ACQUIRE VIRTUALSCOPICS, INC.

EX-99.A1.H Exhibit (a)(1)(H) Contact: BioTelemetry, Inc. Heather C. Getz Investor Relations 800-908-7103 [email protected] BIOTELEMETRY, INC. COMMENCES PREVIOUSLY ANNOUNCED TENDER OFFER TO ACQUIRE VIRTUALSCOPICS, INC. Malvern, PA ? (GLOBE NEWSWIRE) ? April 8, 2016 ? BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health inf

VirtualScopics SC TO-T

SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) BIOTELEMETRY RESEARCH ACQUISITION CORPORATION (Offeror) BIOTELEMETRY, INC. (Parent of Offeror) (Names of Filing Persons) COMMON STOCK, $0.001 PAR VALUE SERIES A CON

VirtualScopics SC TO-C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) BIOTELEMETRY RESEARCH ACQUISITION CORPORATION (Offeror) BIOTELEMETRY, INC. (Parent of Offeror) (Names of Filing Persons) COMMON STOCK, $0.001 PAR VALUE SERIES A CONVERTIBLE

VirtualScopics, Inc. 500 Linden Oaks Rochester, New York 14625

EX-99.2 3 d136845dex992.htm EX-99.2 Exhibit 99.2 VirtualScopics, Inc. 500 Linden Oaks Rochester, New York 14625 585-249-6231 www.virtualscopics.com April 7, 2016 Dear valued VirtualScopics customers and partners, Recently we announced that VirtualScopics entered into a definitive agreement to be acquired by BioTelemetry, Inc., the leading wireless medical technology company focused on the delivery

Set forth below are frequently asked questions (“FAQ”) posted on the Company’s internal website on April 7, 2016:

EX-99.1 2 d136845dex991.htm EX-99.1 Exhibit 99.1 Set forth below are frequently asked questions (“FAQ”) posted on the Company’s internal website on April 7, 2016: What’s happening? VirtualScopics, Inc. (“VirtualScopics”) has entered into an agreement to be acquired by BioTelemetry, Inc. (“BioTelemetry”), for $4.05 per share of common stock. Biotelemetry will also offer investors $336.30 per share

Set forth below are frequently asked questions (“FAQ”) posted on the Company’s internal website on April 7, 2016:

EX-99.1 2 v436479ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Set forth below are frequently asked questions (“FAQ”) posted on the Company’s internal website on April 7, 2016: What’s happening? VirtualScopics, Inc. (“VirtualScopics”) has entered into an agreement to be acquired by BioTelemetry, Inc. (“BioTelemetry”), for $4.05 per share of common stock. Biotelemetry will also offer investors $336.30 per s

VirtualScopics SC14D9C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) VIRTUALSCOPICS, INC. (Names of Persons Filing Statement) Common Stock, par value $0.001 per share Series A Convertible Preferred Stock, par value $0.001 per share Ser

VirtualScopics, Inc. 500 Linden Oaks Rochester, New York 14625

EX-99.2 3 v436479ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 VirtualScopics, Inc. 500 Linden Oaks Rochester, New York 14625 585-249-6231 www.virtualscopics.com April , 2016 Dear valued VirtualScopics customers and partners, Recently we announced that VirtualScopics entered into a definitive agreement to be acquired by BioTelemetry, Inc., the leading wireless medical technology company focused on the deli

VirtualScopics SC14D9C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) VIRTUALSCOPICS, INC. (Names of Persons Filing Statement) Common Stock, par value $0.001 per share Series A Convertible Preferred Stock, par value $0.001 per share Ser

VIRTUALSCOPICS, INC. CANCELS CONFERENCE CALL DUE TO RECENT ANNOUNCEMENT OF THE DEFINITIVE AGREEMENT WITH BIOTELEMETRY, INC.

Exhibit 99.1 FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. CANCELS CONFERENCE CALL DUE TO RECENT ANNOUNCEMENT OF THE DEFINITIVE AGREEMENT WITH BIOTELEMETRY, INC. ROCHESTER, N.Y., March 29, 2016, ?VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will not hold its conference call, or provide its webcast, previously scheduled for Wednesday, M

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) March 29, 2016 VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (Commission File

Subsidiaries of VirtualScopics, Inc.

Exhibit 21 Subsidiaries of VirtualScopics, Inc. Name Jurisdiction of Organization VirtualScopics New York, LLC New York

VirtualScopics FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52018 VIRTUALSCOPICS, INC. (Exa

FIRST LOAN MODIFICATION AGREEMENT

Exhibit 10.24 FIRST LOAN MODIFICATION AGREEMENT This First Loan Modification Agreement (this ?Loan Modification Agreement?) is entered into as of March 24, 2016, by and among (a) SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, M

VirtualScopics SC14D9C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 VIRTUALSCOPICS, INC. (Name of Subject Company) VIRTUALSCOPICS, INC. (Names of Persons Filing Statement) Common Stock, par value $0.001 per share Series A Convertible Preferred Stock, par value $0.001 per share Ser

AGREEMENT AND PLAN OF MERGER dated as of March 25, 2016, by and among BIOTELEMETRY, INC., Biotelemetry Research Acquisition Corporation VIRTUALSCOPICS, INC. Table of Contents

EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER dated as of March 25, 2016, by and among BIOTELEMETRY, INC., Biotelemetry Research Acquisition Corporation and VIRTUALSCOPICS, INC. Table of Contents Article I The Offer 2 The Offer 2 Company Actions 5 Article II The Merger 6 The Merger 6 Merger Closing 6 Effective Time 7 Merger Without Meeting of Stockholders; Effects of the Merger 7 Certificate of Incorpo

Biotelemetry, Inc. signs definitive agreement to acquire Virtualscopics, Inc.

EX-99.1 4 v435383ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Biotelemetry, Inc. signs definitive agreement to acquire Virtualscopics, Inc. MALVERN, PA and ROCHESTER, NY – March 25, 2016 – BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopic

Exclusive Jurisdiction of Delaware Courts

EXHIBIT 3.1 5.10 Exclusive Jurisdiction of Delaware Courts. Unless the corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, o

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 25, 2016 (March 25, 2016) VIRTUALSCOPICS, INC.

VirtualScopics 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 25, 2016 BioTelemetry, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 000-55039 46-2568498 (State or Other Jurisdiction of Incorporation) (Commission F

BIOTELEMETRY, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE VIRTUALSCOPICS, INC.

Exhibit 99.1 BIOTELEMETRY, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE VIRTUALSCOPICS, INC. MALVERN, PA and ROCHESTER, NY – March 25, 2016 – BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial im

VIRTUALSCOPICS, INC. ANNOUNCES AMENDMENT TO EXCLUSIVE MARKETING AGREEMENT WITH PPD; PROVIDES ADDITIONAL OPPORTUNITIES TO DEVELOP NEW BUSINESS RELATIONSHIPS

Exhibit 99.1 FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. ANNOUNCES AMENDMENT TO EXCLUSIVE MARKETING AGREEMENT WITH PPD; PROVIDES ADDITIONAL OPPORTUNITIES TO DEVELOP NEW BUSINESS RELATIONSHIPS ROCHESTER, N.Y., January 22, 2016?VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that it is amending its alliance agreement with PPD, a contract res

AMENDMENT NO. 4 TO STRATEGIC ALLIANCE AGREEMENT

Exhibit 10.1 AMENDMENT NO. 4 TO STRATEGIC ALLIANCE AGREEMENT This Amendment No. 4 (?Amendment?), made this 15th day of January, 2016, by and between PPD Development, L.P., a Delaware limited partnership and successor in interest to PPD Development, LLC, with offices located at 929 North Front Street, Wilmington, NC 28401 (?PPD?) and VirtualScopics, Inc., with an address at 500 Linden Oaks, Second

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

8-K 1 v4294708k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) January 22, 2016 (January 15, 2016) VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000

VIRTUALSCOPICS, INC. EMPLOYMENT AGREEMENT

Exhibit 10.1 VIRTUALSCOPICS, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and effective this 15th day of December, 2015, between VirtualScopics, Inc., a Delaware corporation (the “Company”), and Ronald Way (“Executive Officer”). WITNESSETH WHEREAS, Executive Officer has been serving as Vice President of Operations for the Company since January 3, 2011; WHEREAS, th

VirtualScopics FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 21, 2015 (December 15, 2015) VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04-

CONFIDENTIALITY AND NON-COMPETITION AGREEMENT

Exhibit 10.2 CONFIDENTIALITY AND NON-COMPETITION AGREEMENT THIS CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (this “Agreement”) is made as of this 15th day of December, 2015, by and between VIRTUALSCOPICS, INC., a Delaware corporation with its principal office at 500 Linden Oaks, Rochester, NY 14625 (the “Company”), and RONALD WAY, an individual with a mailing address of 5127 North Road, Canandai

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) November 3, 2015 (October 29, 2015) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-300

Transcript of VirtualScopics, Inc. Third Quarter 2015 Financial Results October 29, 2015

Exhibit 99.1 Trading Under the Symbol: ISDR Transcript of VirtualScopics, Inc. Third Quarter 2015 Financial Results October 29, 2015 Participants James Groff ? Chief Financial Officer Eric Converse ? President and Chief Executive Officer Presentation Operator Greetings, and welcome to the VirtualScopics Third Quarter 2015 Financial Results call. At this time, all participants are in a listen-only

VIRTUALSCOPICS, INC. REPORTS 2015 THIRD QUARTER REVENUES INCREASE 18% FROM PRIOR YEAR PERIOD AND COMPANY ACHIEVES POSITIVE ADJUSTED EBITDA

Exhibit 99.1 FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. REPORTS 2015 THIRD QUARTER REVENUES INCREASE 18% FROM PRIOR YEAR PERIOD AND COMPANY ACHIEVES POSITIVE ADJUSTED EBITDA ROCHESTER, N.Y., October 29, 2015?VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the third quarter and nine months ended September 30, 2015. Rev

Third Quarter 2015 Performance Review October 29, 2015

Exhibit 99.2 Third Quarter 2015 Performance Review October 29, 2015 Forward - looking Statements The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) October 29, 2015 VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (Commission Fi

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) August 17, 2015 (August 11, 2015) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-30071

Transcript of VirtualScopics, Inc. Second Quarter 2015 Financial Results August 11, 2015

Exhibit 99.1 Trading Under the Symbol: ISDR Transcript of VirtualScopics, Inc. Second Quarter 2015 Financial Results August 11, 2015 Participants Eric Converse – President and Chief Executive Officer Jim Groff – Chief Financial Officer Presentation Operator Greetings and welcome to the VirtualScopics' Second Quarter 2015 Financial Results. At this time, all participants are in a listen-only mode.

VIRTUALSCOPICS, INC. REPORTS 2015 SECOND QUARTER AND SIX MONTHS FINANCIAL RESULTS; REVENUES INCREASE 14% FROM 2014 SECOND QUARTER AND 17% ABOVE THE SIX MONTHS REPORTED IN 2014

Exhibit 99.1 DRAFT NOT FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. REPORTS 2015 SECOND QUARTER AND SIX MONTHS FINANCIAL RESULTS; REVENUES INCREASE 14% FROM 2014 SECOND QUARTER AND 17% ABOVE THE SIX MONTHS REPORTED IN 2014 ROCHESTER, N.Y., August 11, 2015?VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the second quarte

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) August 11, 2015 VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (Commission Fil

Second Quarter 2015 Performance Review August 11, 2015 Second Quarter 2015 Financial Review 3 June 30, 2015 Balance Sheet 4 CEO Comments • Double Digit Revenue Growth Continues − Cash burn reduced • $2 Million Line of Credit With Silicon Valley Bank

Exhibit 99.2 Second Quarter 2015 Performance Review August 11, 2015 Forward - looking Statements The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harb

VIRTUALSCOPICS, INC. REPORTS VOTING RESULTS AT ANNUAL MEETING OF SHAREHOLDERS; ALL BOARD SEATS RENEWED

Exhibit 99.1 VIRTUALSCOPICS, INC. REPORTS VOTING RESULTS AT ANNUAL MEETING OF SHAREHOLDERS; ALL BOARD SEATS RENEWED ROCHESTER, N.Y., June 5, 2015—VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that shareholders have voted for and ratified all three proposals contained in the company’s 2015 proxy statement. The outcome of this morning’s v

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) June 5, 2015 (June 2, 2015) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (Co

Transcript of VirtualScopics, Inc. 2015 Annual Meeting June 2, 2015

Exhibit 99.2 Transcript of VirtualScopics, Inc. 2015 Annual Meeting June 2, 2015 Participants Greg Gribben ? Corporate Secretary Eric Converse ? President and Chief Executive Officer Jim Groff ? Chief Financial Officer Ron Way ? Vice President of Operations Michael Barret ? Director of Data Management Team Lianne Cox ? Director of Project Management Presentation Eric Converse ? President and Chief

Annual Shareholders Meeting June 2, 2015 1

Exhibit 99.3 Annual Shareholders Meeting June 2, 2015 1 Meeting Overview 2 Proxy Tally and Results Eric Converse, President and Chief Executive Officer Project and Site Management Lianne Cox, Director of Project Management Data Management Mike Barrett, Director of Data Management Achieving Operational Excellence Ron Way, Vice President of Operations Financial Review Jim Groff, Chief Financial Offi

Regulation FD Disclosure, Financial Statements and Exhibits

EXHIBIT INDEX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) May 8, 2015 (May 6, 2015) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04

Transcript of First Quarter 2015 Conference Call and Webcast May 6, 2015

Exhibit 99.1 Trading Under the Symbol: ISDR Transcript of VirtualScopics First Quarter 2015 Conference Call and Webcast May 6, 2015 Participants James Groff ? Chief Financial Officer Eric Converse ? President and Chief Executive Officer Analysts Keith Gil ? JHS Capital Advisors Presentation Operator Greetings and welcome to VirtualScopics First Quarter 2015 Financial Results. At this time, all the

500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP First Quarter 2015 Performance Review May 6, 2015 1

Exhibit 99.2 500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP First Quarter 2015 Performance Review May 6, 2015 1 The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchan

VIRTUALSCOPICS, INC. REPORTS 2015 FIRST QUARTER FINANCIAL RESULTS; REVENUES INCREASE 20% FROM 2014 FIRST QUARTER

Exhibit 99.1 VIRTUALSCOPICS, INC. REPORTS 2015 FIRST QUARTER FINANCIAL RESULTS; REVENUES INCREASE 20% FROM 2014 FIRST QUARTER ROCHESTER, N.Y., May 6, 2015?VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the first quarter ended March 31, 2015. Revenues for the first quarter of 2015 rose 20% to $2,814,442 compared to re

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) May 6, 2015 VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (Commission File Nu

VirtualScopics DEF 14A

DEF 14A 1 v407959def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 1

VirtualScopics POS AM

As filed with the Securities and Exchange Commission on March 30, 2015 Registration No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2015 (February 11, 2015) VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04

VIRTUALSCOPICS, INC. REPORTS FOURTH QUARTER AND YEAR END 2014 FINANCIAL RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. REPORTS FOURTH QUARTER AND YEAR END 2014 FINANCIAL RESULTS ROCHESTER, N.Y., February 26, 2015—VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the fourth quarter and year ended December 31, 2014. Revenues for the fourth quarter of 2014 were $2,709,511 compared to

Transcript of VirtualScopics, Inc. Fourth Quarter and Full Year 2014 Earnings Call February 26, 2015

Exhibit 99.2 Trading Under the Symbol: ISDR Transcript of VirtualScopics, Inc. Fourth Quarter and Full Year 2014 Earnings Call February 26, 2015 Participants Eric Converse – President and Chief Executive Officer James Groff – Chief Financial Officer Analysts Paul Rodgers – Gold Leaf Capital Management Steve Posage – Posage Roders Presentation Operator Greetings and welcome to the VirtualScopics Fo

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) February 27, 2015 (February 26, 2015) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3

500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Fourth Quarter & Full Year 2014 Performance Review February 26, 2015 1

Exhibit 99.3 500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Fourth Quarter & Full Year 2014 Performance Review February 26, 2015 1 The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of th

ANDREW LEVITCH AND MICHAEL WOEHLER, PH.D. JOIN VIRTUALSCOPICS, INC.’S BOARD OF DIRECTORS; DAVID RUBIN, PH.D. ANNOUNCES RETIREMENT FROM THE BOARD

Exhibit 99.1 FOR IMMEDIATE RELEASE ANDREW LEVITCH AND MICHAEL WOEHLER, PH.D. JOIN VIRTUALSCOPICS, INC.’S BOARD OF DIRECTORS; DAVID RUBIN, PH.D. ANNOUNCES RETIREMENT FROM THE BOARD ROCHESTER, N.Y., February 11, 2015—VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that David Rubin, 49, a director representing the Series C shares of the comp

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 6, 2015 (February 11, 2015) VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04-3

500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Third Quarter 2014 Conference Call November 13, 2014 1

Exhibit 99.2 500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Third Quarter 2014 Conference Call November 13, 2014 1 The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exc

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) November 18, 2014 (November 13, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3

Transcript of VirtualScopics, Inc. Third Quarter 2014 Earnings Call November 13, 2014

Exhibit 99.1 Trading Under the Symbol: ISDR Transcript of VirtualScopics, Inc. Third Quarter 2014 Earnings Call November 13, 2014 Participants Jim Groff – Chief Financial Officer Eric Converse – President and Chief Executive Officer Analysts Paul Rodgers – Gold Leaf Capital Keith Gil – JHS Capital Advisors Presentation Operator Greetings and welcome to the VirtualScopics Third Quarter 2014 Financi

VIRTUALSCOPICS, INC. REPORTS THIRD QUARTER AND NINE MONTHS 2014 FINANCIAL RESULTS; THIRD QUARTER AWARDS OUTSTANDING AND BOOKINGS UP 29%, QUARTERLY REVENUES UP 23% FROM THE PRIOR YEAR

Exhibit 99.1 FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. REPORTS THIRD QUARTER AND NINE MONTHS 2014 FINANCIAL RESULTS; THIRD QUARTER AWARDS OUTSTANDING AND BOOKINGS UP 29%, QUARTERLY REVENUES UP 23% FROM THE PRIOR YEAR ROCHESTER, N.Y., November 13, 2014—VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the third quarter

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) November 13, 2014 (November 13, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3

VIRTUALSCOPICS, INC. EMPLOYMENT AGREEMENT

EXHIBIT 10.1 VIRTUALSCOPICS, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and effective this 19th day of August, 2014, between VirtualScopics, Inc., a Delaware corporation (the “Company”), and James A. Groff (“Executive Officer”). WITNESSETH WHEREAS, Executive Officer has been serving as acting Chief Financial Officer (CFO) for the Company since August 31, 2013; W

CONFIDENTIALITY AND NON-COMPETITION AGREEMENT

EXHIBIT 10.2 CONFIDENTIALITY AND NON-COMPETITION AGREEMENT THIS CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (this "Agreement") is made as of this 19th day of August, 2014, by and between VIRTUALSCOPICS, INC., a Delaware corporation with its principal office at 500 Linden Oaks, Rochester, NY 14625 (the "Company"), and JAMES A. GROFF, an individual with a mailing address of 79 Red Leaf Drive, Roch

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) August 21, 2014 (August 19, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-30071

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) August 15, 2014 (August 14, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-30071

500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Second Quarter 2014 Conference Call August 14, 2014 1

Exhibit 99.2 500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Second Quarter 2014 Conference Call August 14, 2014 1 The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exch

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 v3869188k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) August 14, 2014 (August 14, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of inco

EMPLOYMENT AGREEMENT

EXHIBIT 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and effective this 23rd day of July, 2014, between VirtualScopics, Inc., a Delaware corporation (the “Company”), and Eric T. Converse, Executive Officer, (“Executive Officer”). WITNESSETH WHEREAS, Executive Officer has been acting as interim President and Chief Executive Officer (CEO) for the Company since Octob

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) July 25, 2014 (July 23, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (

CONFIDENTIALITY AND NON-COMPETITION AGREEMENT

EXHIBIT 10.2 CONFIDENTIALITY AND NON-COMPETITION AGREEMENT THIS CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (this "Agreement") is made as of this 23rd day of July, 2014, by and between VIRTUALSCOPICS, INC., a Delaware corporation with its principal office at 500 Linden Oaks, Rochester, NY 14625 (the "Company"), and Eric TIMOTHY Converse, an individual with a mailing address of ("Executive Office

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) June 26, 2014 VIRTUALSCOPICS, INC.

VIRTUALSCOPICS, INC. SIGNS AN ALLIANCE FRAMEWORK AGREEMENT WITH IXICO PLC; COMMERCIAL AND OPERATIONAL ALLIANCE TO PROVIDE CLINICAL TRIALS INDUSTRY WITH GLOBAL CAPABILITIES AND A FULL RANGE OF THERAPEUTIC AREAS AND MODALITY EXPERTISE

FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. SIGNS AN ALLIANCE FRAMEWORK AGREEMENT WITH IXICO PLC; COMMERCIAL AND OPERATIONAL ALLIANCE TO PROVIDE CLINICAL TRIALS INDUSTRY WITH GLOBAL CAPABILITIES AND A FULL RANGE OF THERAPEUTIC AREAS AND MODALITY EXPERTISE Rochester, N.Y. and London, U.K., June 27, 2014—VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, and I

VIRTUALSCOPICS, INC. REPORTS VOTING RESULTS AT ANNUAL MEETING OF SHAREHOLDERS; ALL FOUR PROPOSALS APPROVED

FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. REPORTS VOTING RESULTS AT ANNUAL MEETING OF SHAREHOLDERS; ALL FOUR PROPOSALS APPROVED Rochester, NY, June 19, 2014—VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that shareholders have voted for and ratified all four proposals contained in the company’s 2014 proxy statement. The outcome of yeste

Transcript of VirtualScopics, Inc. 2014 Annual Meeting June 17, 2014

Transcript of VirtualScopics, Inc. 2014 Annual Meeting June 17, 2014 Participants Eric Converse – Interim President & Chief Executive Officer Greg Gribben – Corporate Secretary Jim Groff – Acting Chief Financial Officer Erik Jensen – Vice President of Global Business Development and Marketing John Riek – Chief Technical Officer Ed Ashton – Chief Scientific Officer Presentation Eric Converse – Inte

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 19, 2014 VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04-3007151 (Commission File

500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP 2014 Annual Shareholders’ Meeting June 17, 2014 1 Introductions and Opening Remarks • Eric Converse, Interim President & Chief Executive Office

500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP 2014 Annual Shareholders’ Meeting June 17, 2014 1 Introductions and Opening Remarks • Eric Converse, Interim President & Chief Executive Officer Proxy Summons Financial Review • Jim Groff, Acting Chief Financial Officer Business Development • Erik Jensen, Vice President of Global Business Dev

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION VIRTUALSCOPICS, INC. a Delaware corporation

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF VIRTUALSCOPICS, INC.

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) June 19, 2014 (June 17, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) May 22, 2014 (May 15, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (Co

Transcript of VirtualScopics, Inc. First Quarter 2014 Earnings Call May 15, 2014

Transcript of VirtualScopics, Inc. First Quarter 2014 Earnings Call May 15, 2014 Participants Jim Groff - Acing Chief Financial Officer Eric Converse - Interim Chief Executive Officer Analysts Paul Rodgers - Gold Leaf Capital Management Douglas Russell - Brown Harris Stevens Presentation Operator Greetings, and welcome to the VirtualScopics First Quarter 2014 Financial Results. At this time, all p

First Quarter 2014 Conference Call May 15, 2014 NASDAQ: VSCP First Quarter 2014 Financial Review 4 Business Pipeline – Average Timing 73 Days RFP 35 Days Award Immediate to Backlog Booking 6 Revenue Recognition – Average Cycle 0% 5% 10% 15% 20% 25% 3

First Quarter 2014 Conference Call May 15, 2014 NASDAQ: VSCP Forward Looking Statement • This presentation contains forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) May 15, 2014 (May 15, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (Co

VIRTUALSCOPICS, INC. REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS; AWARDS OUTSTANDING AND BOOKINGS SIGNED MORE THAN TRIPLED 2013 FIRST QUARTER LEVELS

FOR IMMEDIATE RELEASE VIRTUALSCOPICS, INC. REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS; AWARDS OUTSTANDING AND BOOKINGS SIGNED MORE THAN TRIPLED 2013 FIRST QUARTER LEVELS Rochester, NY, May 15, 2014—VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of quantitative imaging solutions, today reported the financial results for the first quarter ended March 31, 2014. Awards outstanding and bookin

- FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

- FORM PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant o Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

Subsidiaries of VirtualScopics, Inc.

Exhibit 21 Subsidiaries of VirtualScopics, Inc. Name Jurisdiction of Organization VirtualScopics New York, LLC New York

VirtualScopics, Inc. Bonus Plan

Exhibit 10.7 VirtualScopics, Inc. Bonus Plan On January 29, 2014, the Registrant?s Compensation Committee approved the terms of the Registrant?s Bonus Plan (?Plan?). The current plan is substantially similar to the bonus plans covering prior fiscal years. The Plan covers the Registrant?s Chief Executive Officer, management employees including the Chief Financial Officer, and other employees. The P

VirtualScopics FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52018 VIRTUALSCOPICS, INC. (Exa

AMENDED AND RESTATED BY-LAWS VIRTUALSCOPICS, INC. Amended and Restated as of March 21, 2014 ARTICLE I

Exhibit 3.11 AMENDED AND RESTATED BY-LAWS Of VIRTUALSCOPICS, INC. Amended and Restated as of March 21, 2014 ARTICLE I OFFICES 1.1 REGISTERED OFFICE. The registered office shall be established and maintained at Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware in the County of New Castle in the State of Delaware. 1.2 OTHER OFFICES. The corporation may have other offices, either wit

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) March 27, 2014 (March 21, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151

Text of Previous Article III, Sections 3.1 and 3.5:

EXHIBIT 3.1 Text of Previous Article III, Sections 3.1 and 3.5: 3.1 NUMBER AND TERM. The number of directors shall be 1 to 9. The directors shall be elected at the annual meeting of the stockholders and each director shall be elected to serve until his successors shall be elected and shall qualify. The number of directors may not be less than three except that where all the shares of the corporati

SERVICES AGREEMENT EXTENSION AGREEMENT

Exhibit 10.1 SERVICES AGREEMENT EXTENSION AGREEMENT This Services Agreement Extension Agreement (this “Agreement”) is entered into by and between VirtualScopics, Inc., a Delaware corporation with its principal office at 500 Linden Oaks, Rochester, NY 14625 (the “Company”), and Converse & Company, a New Jersey corporation with its principal office at P.O. Box 15, Mechanicsville, PA 18934 (the “Serv

VirtualScopics Reports Fourth-Quarter and Full-Year 2013 Results Awards and Bookings Double in 2013, Momentum Continues in Early 2014 with First-Ever Program Award

500 Linden Oaks Rochester, New York 14625 VirtualScopics Reports Fourth-Quarter and Full-Year 2013 Results Awards and Bookings Double in 2013, Momentum Continues in Early 2014 with First-Ever Program Award ROCHESTER, NY – March 7, 2014 – VirtualScopics, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported) March 7, 2014 (March 7, 2014) VIRTUALSCOPICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-52018 04-3007151 (

Other Events - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 4, 2014 (March 4, 2014) VIRTUALSCOPICS, INC.

VirtualScopics Q3 2013 Earnings Call Thursday, November 14, 2013 – 11 am (ET)

Page | 1 VirtualScopics Q3 2013 Earnings Call Thursday, November 14, 2013 – 11 am (ET) Conference Call Operator will introduce Nicole Schoenberg who will discuss the duration of the call, the format – she will also introduce management.

VirtualScopics Reports Third Quarter 2013 Results and the Doubling of YTD Awards and Bookings

EXHIBIT 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Reports Third Quarter 2013 Results and the Doubling of YTD Awards and Bookings ROCHESTER, NY – November 14, 2013 – VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced revenues of $2,227,877 for the quarter ended September 30, 2013 compared to $3,328,217 for the quarter ended September

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 14, 2013 (November 14, 2013) VIRTUALSCOPICS, INC.

VirtualScopics’ Board of Directors Appoints Eric Converse Interim Chief Executive Officer, Announces Resignation of Jeff Markin Korn/Ferry Retained to Initiate Search for Next CEO

Contact: Nicole Schoenberg FleishmanHillard 212-453-2445 [email protected] VirtualScopics’ Board of Directors Appoints Eric Converse Interim Chief Executive Officer, Announces Resignation of Jeff Markin Korn/Ferry Retained to Initiate Search for Next CEO ROCHESTER, N.Y. October 25, 2013 – Mostafa Analoui Ph.D., Chairman of the Board of Directors of VirtualScopics, Inc. (NASDAQ: VSCP)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 25, 2013 VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04-3007151 (Commission F

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) September 4, 2013 (August 29, 2013) VIRTUALSCOPICS, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 28, 2013 VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04-3007151 (Commission Fi

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

8-K 1 v3534898-k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 21, 2013 VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-5

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION VIRTUALSCOPICS, INC. a Delaware corporation

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF VIRTUALSCOPICS, INC.

VirtualScopics Announces 1-for-10 Reverse Stock Split

500 Linden Oaks Rochester, New York 14625 VirtualScopics Announces 1-for-10 Reverse Stock Split ROCHESTER, NY – August 21, 2013 – VirtualScopics, Inc.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 13, 2013 VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04-3007151 (Commission Fi

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) (August 13, 2013) August 13, 2013 VIRTUALSCOPICS, INC.

Annual Stockholders’ Meeting August 13, 2013

Annual Stockholders’ Meeting August 13, 2013 VirtualScopics All Rights Reserved 2 Meeting Overview Introductions and Opening Remarks • Robert Klimasewski, Chairman Proxy Summons Business Overview • Jeff Markin/Molly Henderson Question and Answer Proxy Tally and Results • Robert Klimasewski VirtualScopics All Rights Reserved 3 2013 Proxy Summons Election of Board of Directors for 2013/2014 Ratify t

VirtualScopics Reports Second Quarter 2013 Results

VirtualScopics Reports Second Quarter 2013 Results 14% Increase in Second Quarter 2013 Revenues ROCHESTER, N.

Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) August 13, 2013 (August 13, 2013) VIRTUALSCOPICS, INC.

Advance to Slide 6

Advance to Slide 6 MARKIN: Before I begin my prepared remarks I would like to recognize members of the Executive Management team who are at the meeting today.

- DEFINITIVE PROXY STATEMENT

DEF 14A 1 v349210def14a.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant o Filed by a Party other than the Registrant o Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Comm

- FORM PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ¨ Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2 )) ¨ Defin

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 v3479748k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 12, 2013 VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-5201

VirtualScopics’ Chief Financial Officer to Resign Ms. Henderson Relocating to Europe

Exhibit 99.1 VirtualScopics’ Chief Financial Officer to Resign Ms. Henderson Relocating to Europe ROCHESTER, NY – June 14, 2013 – VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced that on June 12, 2013 Molly Henderson, it’s Chief Business and Financial Officer, Sr. Vice President notified the company of her intention to resign from the company effecti

Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 14, 2013 VIRTUALSCOPICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-52018 04-3007151 (Commission File

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 15, 2013 (May 15, 2013) VIRTUALSCOPICS, INC.

VirtualScopics Reports First Quarter 2013 Results Awards and Bookings Advance 40% over Year to Date 2012

VirtualScopics Reports First Quarter 2013 Results Awards and Bookings Advance 40% over Year to Date 2012 ROCHESTER, N.

Financial Statements and Exhibits, Results of Operations and Financial Condition

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 19, 2013 (February 19, 2013) VIRTUALSCOPICS, INC.

VirtualScopics Reports Fourth-Quarter and Full-Year 2012 Results

EXHIBIT 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Reports Fourth-Quarter and Full-Year 2012 Results ROCHESTER, NY – February 19, 2013 – VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced revenues of $12,963,164 for the year ended December 31, 2012 compared to $14,281,603 for the year ended December 31, 2011. Net loss for the twelve

VirtualScopics Reports 3rd Quarter 2012 Results Earnings call scheduled for 11am ET today

EXHIBIT 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Reports 3rd Quarter 2012 Results Earnings call scheduled for 11am ET today ROCHESTER, NY – November 9, 2012 – VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative medical imaging, today reported revenues of $3,328,217 for the third quarter of 2012 compared to revenues of $3,268,807 in the third quarter of 2011

Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 9, 2012 (November 9, 2012) VIRTUALSCOPICS, INC.

VirtualScopics Announces Receipt of Notice from Nasdaq

500 Linden Oaks Rochester, New York 14625 VirtualScopics Announces Receipt of Notice from Nasdaq ROCHESTER, NEW YORK – August 31, 2012 - VirtualScopics, Inc.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) August 31, 2012 (August 29, 2012) VIRTUALSCOPICS, INC.

VirtualScopics Reports 2nd Quarter 2012 Results Earnings call scheduled for 11am ET today

EXHIBIT 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Reports 2nd Quarter 2012 Results Earnings call scheduled for 11am ET today ROCHESTER, NY – August 14, 2012 – VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today reported revenues of $3,335,861 for the second quarter of 2012 compared to revenues of $3,852,925 in the second quarter of 2011. Gross

Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) August 14, 2012 (August 14, 2012) VIRTUALSCOPICS, INC.

AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF THE SERIES B PREFERRED STOCK VIRTUALSCOPICS, INC. (Pursuant to Section 151 of the General Corporation Law of the State of Delaware)

AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF THE SERIES B PREFERRED STOCK OF VIRTUALSCOPICS, INC.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) June 18, 2012 (June 12, 2012) VIRTUALSCOPICS, INC.

AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, POWERS, PREFERENCES AND OTHER RIGHTS AND QUALIFICATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK (Pursuant to Section 151 of the Delaware General Corporation Law)

AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, POWERS, PREFERENCES AND OTHER RIGHTS AND QUALIFICATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK (Pursuant to Section 151 of the Delaware General Corporation Law) The undersigned, Molly Henderson, Chief Business and Financial Officer, Senior Vice President and Corporate Secretary, does hereby certify that: A.

VirtualScopics, Inc. Annual Stockholders’ Meeting June 12, 2012 Business Portion of Annual Meeting Script Advance to Slide 6

VirtualScopics, Inc. Annual Stockholders’ Meeting June 12, 2012 Business Portion of Annual Meeting Script Advance to Slide 6 MARKIN: Before I begin my prepared remarks I would like to recognize members of the Executive Management team who are at the meeting today. They are: Erik Jensen - Vice President of Global Marketing and Business Development, Ron Way- Director of Operations, Nicole Vespone –

Annual Stockholders’ Meeting June 12, 2012

Annual Stockholders’ Meeting June 12, 2012 VirtualScopics All Rights Reserved 2 Meeting Overview Introductions and Opening Remarks • Robert Klimasewski, Chairman Proxy Summons Business Overview • Jeff Markin/Molly Henderson Question and Answer Proxy Tally and Results • Robert Klimasewski VirtualScopics All Rights Reserved 3 2012 Proxy Summons Election of Board of Directors for 2012/2013 Ratify the

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) (June 12, 2012) June 12, 2012 VIRTUALSCOPICS, INC.

VirtualScopics Reports 1st Quarter 2012 Results Earnings call scheduled for 11am ET today

EXHIBIT 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Reports 1st Quarter 2012 Results Earnings call scheduled for 11am ET today ROCHESTER, NY – May 15, 2012 – VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today reported revenues for the first quarter of 2012 reached $3,702,159 compared to revenues of $3,658,977 in the first quarter of 2011. Gross

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 15, 2012 (May 15, 2012) VIRTUALSCOPICS, INC.

- DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ¨ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2 )) x Defin

VSCP / VirtualScopics, Inc. / Merck Global Health Innovation Fund, LLC Activist Investment

SC 13D 1 mercksc13d.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* VIRTUALSCOPICS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 928269-10-9 (CUSIP Number) William Taranto, Manager / President Merck Global Health Innovation Fund, LLC One Merck Drive Whitehouse Station, NJ 08889

- FORM PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant o Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2 )) ¨ Defin

VOTING AGREEMENT

Exhibit 10.6 VOTING AGREEMENT This Voting Agreement (this “Agreement”), dated as of March 27, 2012 between the undersigned stockholder (“Stockholder”) of VirtualScopics, Inc., a Delaware corporation (the “Company”), and the Company. WHEREAS, concurrently with or following the execution of this Agreement, the Company and Merck Global Health Innovation Fund, LLC, a Delaware limited liability company

INDEMNIFICATION AGREEMENT

Exhibit 10.7 INDEMNIFICATION AGREEMENT This Indemnification Agreement, dated as of April 3, 2012, is made by and between VirtualScopics, Inc., a Delaware corporation (the “Corporation”) and David Rubin (the “Indemnitee”). RECITALS A. The Corporation recognizes that competent and experienced persons are increasingly reluctant to serve or to continue to serve as directors or officers of corporations

SERIES C PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT

SERIES C PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT THIS SERIES C PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made as of the 3rd day of April, 2012, by and between VirtualScopics, Inc.

- EXHIBIT 3.1

Exhibit 3.1 CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF THE SERIES C-1 PREFERRED STOCK AND THE SERIES C-2 PREFERRED STOCK OF VIRTUALSCOPICS, INC. (Pursuant to Section 151 of the General Corporation Law of the State of Delaware) It is hereby certified that: 1. The name of the Corporation (hereinafter called the “Corporation”) is VirtualScopics, Inc., a Delaware corporation. For purposes

VOTING AGREEMENT

Exhibit 10.5 VOTING AGREEMENT This Voting Agreement (this “Agreement”), dated as of March 29, 2012 between the undersigned stockholder (“Stockholder”) of VirtualScopics, Inc., a Delaware corporation (the “Company”), and the Company. WHEREAS, concurrently with or following the execution of this Agreement, the Company and Merck Global Health Innovation Fund, LLC, a Delaware limited liability company

Warrant to Purchase Common Stock VirtualScopics, Inc.

Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (i) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S

VOTING AGREEMENT

Exhibit 10.3 VOTING AGREEMENT This Voting Agreement (this “Agreement”), dated as of March 28, 2012 between the undersigned stockholder (“Stockholder”) of VirtualScopics, Inc., a Delaware corporation (the “Company”), and the Company. WHEREAS, concurrently with or following the execution of this Agreement, the Company and Merck Global Health Innovation Fund, LLC, a Delaware limited liability company

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders - CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 4, 2012 (April 3, 2012) VIRTUALSCOPICS, INC.

INVESTOR RIGHTS AGREEMENT

Exhibit 10.2 INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made as of the 3rd day of April, 2012, by and between VirtualScopics, Inc. a Delaware corporation (the “Company”), and Merck Global Health Innovation Fund LLC, a Delaware limited liability company (the “Investor”). RECITALS WHEREAS, the Company and Investor are parties to the Series C Preferred Stock and War

Amended and Restated Warrant to Purchase Common Stock VirtualScopics, Inc.

Exhibit 4.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (i) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S

VirtualScopics Receives Investment in New Business Venture from the Merck Global Health Innovation Fund Investment of up to $6 million will support commercialization of company's personalized medicine applications

VirtualScopics 500 Linden Oaks Rochester, New York 14625 VirtualScopics Receives Investment in New Business Venture from the Merck Global Health Innovation Fund Investment of up to $6 million will support commercialization of company's personalized medicine applications ROCHESTER, NY - April 4, 2012 - VirtualScopics, Inc.

VOTING AGREEMENT

Exhibit 10.4 VOTING AGREEMENT This Voting Agreement (this “Agreement”), dated as of March 27, 2012 between the undersigned stockholder (“Stockholder”) of VirtualScopics, Inc., a Delaware corporation (the “Company”), and the Company. WHEREAS, concurrently with or following the execution of this Agreement, the Company and Merck Global Health Innovation Fund, LLC, a Delaware limited liability company

VirtualScopics Reports Fourth-Quarter and Full-Year 2011 Results; 2011 Revenues Increase 7%

EXHIBIT 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Reports Fourth-Quarter and Full-Year 2011 Results; 2011 Revenues Increase 7% 2011 Adjusted EBITDA Exceeds $1,400,000 ROCHESTER, NY – February 21, 2012 – VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging for clinical trials, today announced revenues of $14,281,603 for the year ended December 31, 2011

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 21, 2012 (February 21, 2012) VIRTUALSCOPICS, INC.

VirtualScopics Regains Nasdaq Compliance

Exhibit 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Regains Nasdaq Compliance ROCHESTER, New York – February 9, 2012 - VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of quantitative imaging for clinical trials, today announced that it has received notification from The Nasdaq Stock Market that it has regained compliance with the minimum $1.00 per share bid price requireme

Other Events, Financial Statements and Exhibits - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 10, 2012 (February 9, 2012) VIRTUALSCOPICS, INC.

AMENDMENT NO. 1

Exhibit 10.1 AMENDMENT NO. 1 This Amendment No. 1 (“Amendment”), made this the 29th day of December, 2011 (“Effective Date”), by and between PPD Development, LP, a Texas limited partnership with offices located at 929 North Front Street, Wilmington, NC 28401 (“PPD”) and VirtualScopics, Inc., with an address of 500 Linden Oaks, Second Floor, Rochester, New York 14625 (“VS”), shall be an amendment t

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) January 26, 2012 (January 24, 2012) VIRTUALSCOPICS, INC.

VirtualScopics Announces Receipt of Notice from Nasdaq

EXHIBIT 99.1 500 Linden Oaks Rochester, New York 14625 VirtualScopics Announces Receipt of Notice from Nasdaq ROCHESTER, NEW YORK - January 6, 2012 - VirtualScopics, Inc., (NASDAQ: VSCP), a leading provider of image-based solutions to the pharmaceutical, biotechnology and medical device industries, announced today that on January 4, 2012 it received a notice from the NASDAQ Stock Market indicating

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits - CURRENT REPORT ON FORM 8-K

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) January 6, 2012 (January 4, 2012) VIRTUALSCOPICS, INC.